Detailed price information for Quantum Biopharma Ltd (QNTM-Q) from The Globe and Mail including charting and trades.
Detailed price information for Quantum Biopharma Ltd (QNTM-Q) from The Globe and Mail including charting and trades.
Target biopharma, gene editing and sustainable agriculture; leverage regional and competitive insights to uncover revenue opportunities and guide R&D investmentDublin, Nov. 11, 2026 (GLOBE NEWSWIRE) -- "Biotechnology - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global biotechnology market was valued at US$2.1 trillion in 2025 and is projected to reach US$5.0 trillion by 2032, expanding at a compound annual growth rate (CAGR) of 13.3%. Market growth
Thermo Fisher Scientific (NYSE:TMO) is emerging as a key supplier in the global cell sheet-based gene therapy market, which is gaining attention in regenerative medicine in 2026. Sector milestones in cell sheet-based therapies for tissue repair and organ regeneration have highlighted Thermo Fisher Scientific's tools, platforms, and services used by developers in this field. Thermo Fisher Scientific's involvement in cell sheet technologies extends the business further into advanced gene and...
Liontrust Investment Partners recently released its “GF Global Dividend Fund” Q3 2026 investor letter. A copy of the letter can be downloaded here. The Fund returned -0.6% in the third quarter of 2026, underperforming the MSCI AC World Index, which gained 1.6%. However, the Fund remained ahead of the benchmark year to date, with a […]
Cut costs and accelerate safety assessments with human-relevant in vitro models, AI, organ-on-chip and high-throughput screening amid regulatory and ethical shifts.Dublin, Nov. 10, 2026 (GLOBE NEWSWIRE) -- "In Vitro Toxicology Testing - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global in vitro toxicology testing market was valued at US$14 billion in 2025 and is projected to reach US$27.4 billion by 2032, expanding at a compound annual growth rate
Thermo Fisher Scientific (NYSE:TMO) approved a new US$5b share repurchase program, replacing its prior authorization. The refreshed buyback plan gives the life sciences group additional capacity to retire stock through future share repurchases. The new authorization indicates Thermo Fisher Scientific intends to continue returning capital to shareholders through ongoing share repurchase activity. There is more to Thermo Fisher Scientific than the newly approved US$5b share repurchase program...
Boost ROI with automation, single-use systems, continuous processing and real-time analytics that reduce costs, accelerate purification, and improve yield and product quality.Dublin, Nov. 04, 2026 (GLOBE NEWSWIRE) -- "Downstream Processing - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering. The global downstream processing market was valued at US$46.4 billion in 2025 and is projected to reach US$128.9 billion by 2032, expanding at a compound annual growt
Marc Casper, Thermo Fisher chairman, president, and CEO, joins 'Mad Money' host Jim Cramer to talk quarterly results, working in China, and more.
This is the newest page. Registered accounts read further back.